FindTrial
Sign In

To evaluate macular and peripapillary microvascular changes in systemic hypertension as measured by optical coherence tomography angiography technology

Evaluation of macular and peripapillary microvascular changes in systemic hypertension as measured by optical coherence tomography angiography

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/04/041654
Enrollment
120
Registered
2022-04-05
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H350- Background retinopathy and retinalvascular changes

Interventions

None listed

Sponsors

Department of Ophthalmology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Hypertensive patients on medication for more than 5 years 2.Age: 30-60 years 3.BCVA � 6/12

Exclusion criteria

Exclusion criteria: 1.Significant ocular media opacity (in order to maximize good quality images) 2.Grade 3 hypertensive retinopathy and above (according to Keith Wagener Barker classification). 3.Any other ocular pathology, e.g. macular edema, diabetic retinopathy, optic nerve disorders etc. 4.Any intraocular surgery 5.Any other systemic illness. 6.Refractive errors ( > +3 D, axial length (AL) >26.0 mm)

Design outcomes

Primary

MeasureTime frame
1-To measure Macular and peripapillary OCTA parameters (VD, PD and FAZ dimensions) in systemic hypertension vs control group.Timepoint: Baseline—

Secondary

MeasureTime frame
1) Measurement of structural OCT Parameters (CMT, GC-IPL and RNFL thicknesses) in systemic hypertension vs normal control group. Timepoint: Baseline—

Countries

India

Contacts

Public ContactDr Yashi Gupta

Maulana Azad Medical college and Associated Guru Nanak Eye Centre, New Delhi

meenakshithakar147@gmail.com9873976836

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026